Medication Oral Medications Symptom Management Surgery and Chemotherapy Antibiotic Treatment Chronic Pain Food Allergy Treatments Alternative Therapies Antibiotics Gene Therapy Cost Considerations Stereotactic Radiosurgery Innovative Therapies Experimental Therapies Disease Management Clinical Trials Cancer Treatment Gene Therapy Risks Clinical Outcomes Oncology Treatments Advanced Cancer Therapeutics Experimental Treatments Systemic Corticosteroids Amoebic Meningoencephalitis Individualized Management Infection Management Therapeutic Approaches Non-Opioid Treatments Disease Progression Research Needs Pharmacotherapy Personalized Medicine Antibiotics and Anti-Inflammatory Medicines Drug Therapies Patient Trials Medications Therapeutic Innovations Medication Access Drug Efficacy Laughter Therapy Artificial Tears
The deal would bring Halda’s RIPTAC technology plus prostate cancer pill HLD-0915 under J&J pending antitrust clearance.
